• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORPORETION LIPOSORBER LA-15 SYSTEM; APHERESIS FOR FOCAL GLOMERULOSCLEROSIS IN ADULT AND PEDIATRIC PATIENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORPORETION LIPOSORBER LA-15 SYSTEM; APHERESIS FOR FOCAL GLOMERULOSCLEROSIS IN ADULT AND PEDIATRIC PATIENTS Back to Search Results
Model Number LA-15
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problem Unspecified Kidney or Urinary Problem (4503)
Event Date 04/20/2022
Event Type  Injury  
Event Description
The patient's fifth liposorber treatment was completed on (b)(6) 2022.The site reported no device issues or complications during treatment.The patient was hospitalized from (b)(6) 2022 due to acute kidney injury and was released when recovered.Patient also was reported to have shortness of breath and chest pain which were assessed as not related to liposorber treatment by the physician.The acute kidney injury relationship to treatment with liposorber was assessed as unknown.However, the physician has continuing the patient on liposorber treatments.
 
Manufacturer Narrative
The device history records (dhr) of the device concerned was reviewed.The production lot, to which the device concerned belongs, passed all in-process inspections test.No nonconformity or abnormality in the manufacturing processes of the device concerned was found.Our view; the facility has not reported any defects and malfunction in the product, and we determine that it is due to the patient's condition and usage.However, since health hazards to patients have occurred, and the causal relationship between health hazards and the product cannot be completely ruled out, we will submit mdr (30 days).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIPOSORBER LA-15 SYSTEM
Type of Device
APHERESIS FOR FOCAL GLOMERULOSCLEROSIS IN ADULT AND PEDIATRIC PATIENTS
Manufacturer (Section D)
KANEKA CORPORETION
nakanoshima
kita-ku 2-3-18
osaka, 530-8 288
JA  530-8288
Manufacturer (Section G)
KANEKA CORPORATION OSAKA PLANT
5-1-1 torikai-nishi
settsu-city, osaka
56600 72
JA   5660072
Manufacturer Contact
joji sengoku
1-12-32
akasaka minato-ku tokyo
JA   1071152
MDR Report Key15435433
MDR Text Key300032572
Report Number3002808904-2022-00011
Device Sequence Number1
Product Code PBN
UDI-Device Identifier14993478010110
UDI-Public14993478010110
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P910018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Distributor
Reporter Occupation Other
Type of Report Initial
Report Date 07/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/16/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/28/2023
Device Model NumberLA-15
Device Catalogue Number101785
Device Lot NumberLAP1585-A1603/A1604
Was Device Available for Evaluation? No
Date Manufacturer Received08/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/23/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization;
Patient Age61 YR
Patient SexMale
Patient Weight91 KG
-
-